MicroRNA biomarkers of Parkinson’s disease in serum exosome-like microvesicles-Reference-Cited by-同舟云学术

MicroRNA biomarkers of Parkinson’s disease in serum exosome-like microvesicles

Published:2017-03 Issue: Volume:644 Page:94-99
ISSN:0304-3940
Container-title:Neuroscience Letters
language:en
Short-container-title:Neuroscience Letters

Author:

Cao Xiang-Yang,Lu Jing-Min,Zhao Zhi-Qiang,Li Ming-Chao,Lu Ting,An Xu-Sheng,Xue Liu-Jun

Publisher

Elsevier BV

Subject

General Neuroscience

Reference34 articles.

1. Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder;Alexander;Dialog. Clin. Neurosci.,2004

2. Clinical features and multidisciplinary approaches to dementia care;Grand;J. Multidiscip. Healthc.,2011

3. Parkinson's disease;Clarke;BMJ,2007

4. Parkinson’s disease: clinical features and diagnosis;Jankovic;J. Neurol. Neurosurg. Psychiatry,2008

5. Neuroinflammation in Parkinson’s disease: a target for neuroprotection;Hirsch;Lancet Neurol.,2009

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Updates on the Role of MicroRNA in the Diagnosis and Treatment of Neurodegenerative Diseases;Current Gene Therapy;2024-04

2. Extracellular Vesicles as Biomarkers for Parkinson’s Disease: How Far from Clinical Translation?;International Journal of Molecular Sciences;2024-01-17

3. The molecular mechanism of miRNA-195-5p regulating ERK involvement in abnormal phosphorylation of Tau protein by aluminum maltol in PC12 cells;2023-12-14

4. The Landscape of Biomimetic Nanovesicles in Brain Diseases;Advanced Materials;2023-12-03

5. Neuroprotective Effects of Wharton Jelly Stem Cell-Derived Exosomes Developed as Nano-Drug Delivery System in 6-OHDA-Induced Neurotoxicity in 2D and 3D Neuronal Cell Line;Regenerative Engineering and Translational Medicine;2023-11-16